Cologuard tests the stool samples provided by the tester and uses the multi-target detection method to analyze the protein and DNA biomarkers related to colorectal cancer and precancerous lesions, mainly including hemoglobin FIT, and DNA site mutation (KRAS gene), DNA methylation. This evidence concerns the gene KRAS and colorectal cancer.